AKT1 and Cognitive impairment: Additional research has verified that ginsenoside Rg2 reduces cognitive impairment caused by Aβ25-35, raises the Bcl-2/Bax ratio, and prevents the rat model of caspase-3 cleavage by initiating the PI3K/Akt pathway (Cui et al., 2021).